S1 Guideline: Diagnosis and therapy of vitiligo
- PMID: 35246935
- DOI: 10.1111/ddg.14713
S1 Guideline: Diagnosis and therapy of vitiligo
Abstract
Vitiligo is a common skin disorder characterized by immune-mediated destruction of melanocytes. Non-segmental vitiligo, the most common clinical subtype, has usually a chronic course and often results in significant psychosocial consequences for the affected patient. Early recognition, awareness of comorbidity, precise assessment of disease extent and activity, evaluation of impairment of quality of life as well as rapid initiation of treatment based on currently available evidence-based therapies are crucial cornerstones in the management of vitiligo. This S1 guideline helps German dermatologists to better diagnose and treat vitiligo.
© 2022 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.
References
-
- Ezzedine K, Lim HW, Suzuki T, Katayama I et al. Revised classification/nomenclature of vitiligo and related issues: The Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res 2012; 25: E1-13.
-
- van Geel N, Speeckaert R, Taieb A, Picardo M et al. Koebner’s phenomenon in vitiligo: European position paper. Pigment Cell Melanoma Res 2011; 24: 564-73.
-
- Silverberg NB. Update on childhood vitiligo. Curr Opin Pediatr 2010; 22: 445-52.
-
- Van Geel N, De Lille S, Vandenhaute S, Gauthier Y et al. Different phenotypes of segmental vitiligo based on a clinical observational study. J Eur Acad Dermatol Venereol 2011; 25: 673-8.
-
- Hann SK, Lee HJ. Segmental vitiligo: clinical findings in 208 patients. J Am Acad Dermatol 1996; 35: 671-4.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical